How much has growth of ‘reasonable and necessary’ medical treatments reduced US mortality?
- 27 April 2026
- journal article
- Published by Taylor & Francis in Economics of Innovation and New Technology
- p. 1-16
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The impact of biomedical innovation on US mortality, 1999–2019: evidence partly based on 286 million descriptors of 27 million PubMed articlesJournal of Demographic Economics, 2025
- Medicare Local Coverage Determinations: Evidence Quality Is Stronger For Covered IndicationsHealth Affairs, 2024
- The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countriesEconomics & Human Biology, 2022
- What is replication?PLOS Biology, 2020
- The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use FilesForum for Health Economics and Policy, 2013
- Investment in vintage capitalJournal of Economic Theory, 2012
- Shall we Really do it Again? The Powerful Concept of Replication is Neglected in the Social SciencesReview of General Psychology, 2009
- Sources of U.S. Economic Growth in a World of IdeasAmerican Economic Review, 2002
- Endogenous Technological ChangeJournal of Political Economy, 1990
- On the Performance of PatentsEconometrica, 1985